Home » Topics » BioWorld

BioWorld
RSS

CENTOCOR'S SEPSIS STUDY COMES UNDER FIRE

July 25, 1991

SYNERGEN REACQUIRES TROFAK RIGHTS

July 24, 1991

NEWS BRIEFS

July 24, 1991

ENZYTECH TO DEVELOP MAb DELIVERY FOR CENTOCOR

July 24, 1991

TRIPLEX COMPLETES $12.2M PRIVATE PLACEMENT

July 24, 1991

CETUS DRUG PORTFOLIO DIFFICULT TO VALUE

July 24, 1991

CETUS TO SELL PCR TECHNOLOGY

July 23, 1991

CHIRON-CETUS MERGER AT A GLANCE

July 23, 1991

BEARISH REACTION TO CETUS-CHIRON DEAL

July 23, 1991

RIBI AMENDS PACT WITH D. BLECH

July 22, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...